Generative AI approach unlocks path to accelerated antibody drug creation for novel therapeutic targets

Group of the scientists working at the laboratory

A recent study used generative AI models to develop de novo design antibodies against three distinct targets in a zero-shot fashion.

Easy Ways to Save a Few Extra Dollars Each Month in 2023

Previous article

Authentic vibes dry up when whiskey brands outsource

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News